Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06363630
Status:
COMPLETED
Last Update Posted:
2024-05-16
First Post:
2024-04-09
Brief Title:
A Study to Evaluate the Effect of Cytochrome P450 CYP 3A Inhibitor Itraconazole and Inducer Rifampin on the Drug Levels of Golcadomide BMS-986369 in Healthy Participants
Sponsor:
Organization:
Celgene
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
36
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: